Skip to content
Search

Latest Stories

NPA board update: David Thomas succeeds Raj Aggarwal OBE

David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.


Ashley Cohen, Sanjeev Panesar, Sukhi Basra, Salim Jetha, Olivier Picard, and Nick Kaye continue their terms without needing to stand for election this time. They still have another two years to run on their terms as board members.

Two board positions remain open. The nomination process is ongoing in Northern Ireland, while in England, five NPA members are contesting the remaining seat, which is open to any member with up to five pharmacies.

The NPA provided Pharmacy Business with the names of the five candidates. They are:
  1. Baba Akomolafe
  2. James Famakin
  3. Simon Harris
  4. Matt Harvey
  5. Mike Hewitson

Hustings for this final board position in England will take place shortly and a ballot for this position will take place later this month, the NPA said.

Recruitment is also currently underway for the new chief executive to succeed Paul Rees.  

Paul Rees MBE stepped down as NPA chief executive in the new year to take on a new role as interim chief executive and registrar of the Nursing and Midwifery Council (NMC).

He joined the NMC on a one-year contract starting January 20, where he is responsible for overseeing the development of a multi-year programme aimed at transforming the NMC’s culture and performance.

New Board to resume work in April 

The current Board will hold its final meetings on 10–11 March, with the newly elected members assuming their roles in April.

NPA chair Nick Kaye welcomed Thomas to the board, which he described as “the dynamic, diverse and innovative national leadership of independent community pharmacy”.

On his new role, David said: “It’s a great privilege and I’ll do my utmost to ensure that NPA members in Wales are well represented and supported throughout my period on the board.”

Raj Aggarwal OBE, a longstanding board member, will step down from the position after more than a decade of service.

Under the NPA’s modified governance cycle, around half of the board positions are up for election every two years.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less